Vern Norris
February 20, 2018
For more than two decades, I’ve kept a photograph of Vern Norris on my office desk. I’ve intended this to be a daily reminder that much of what we are able to do now is due at least in part to people who have come before us.
Vern died recently at the age of 89, nearly 32 years after his retirement, having served on the MHSAA staff for 23 years, including as executive director from 1978 to 1986. He had been in declining health during the past year, but not declining spirit. Many people remember Vern as one who would be willing to help almost anyone at any time.
When, in Kansas City, I read his retirement announcement early in 1986, I sent him a congratulatory note. He responded with a personal call during which he asked of my interest in the job. Given my situation at the time – not on staff, not in the state and not in a school or sports administration – this seemed like a wild pitch. But he encouraged me to think about it and, well, the rest is history.
When I leave this job that I have now held and mostly loved for nearly 32 years so far, I intend to follow Vern’s lead. His was a most graceful exit. We spent only five days together in the MHSAA office; and while his advice since then has been rare, his support has always been well done.
I will miss seeing him at this winter’s tournaments and at the Officials Banquet May 5, an event that he began in his first year as MHSAA executive director, an event where we will honor another of Michigan’s officiating leaders with the “Vern L. Norris Award.”
Cardiac Screening
October 31, 2014
Sudden death among 12 to 25-year-olds is “a low event rate occurrence.”
“There is insufficient information to support the view that ECGs in asymptomatic young people for cardiac disease is appropriate or possible on a national basis for the United States, in competitive athletics or in the general population.”
“At present, there is no mechanism available in the United States to effectively create national programs of such magnitude, whether limited to athletics or including the wider population of all young people.”
“There is insufficient evidence that particularly large-scale/mass screening initiatives are feasible or cost effective within the current US healthcare infrastructure . . .”
“The ECG . . . cannot be regarded as an ideal or effective test when applied to large healthy populations.”
“An additional, but unresolved, ethical issue concerns whether students who voluntarily engage in competitive athletic programs should have advantage of cardiovascular screening, while others who choose not to be involved in such activities (but may be at the same or similar risk) are in effect excluded from the same opportunity.”
The AHA’s Sept. 14 AHA writing group “does not believe the available data support significant public health benefit from using the 12-lead ECG as a universal screening tool. The writing group, however, does endorse the widespread dissemination of automated external defibrillators which are effective in saving young lives on the athletic field and elsewhere.”